ENVESTNET ASSET MANAGEMENT INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,192,580
-12.8%
79,528
-4.9%
0.00%0.0%
Q2 2023$2,513,189
-1.7%
83,606
-81.7%
0.00%0.0%
Q1 2023$2,556,748
-17.2%
456,415
+427.0%
0.00%
-50.0%
Q4 2022$3,089,334
+15.7%
86,609
+9.8%
0.00%0.0%
Q3 2022$2,671,000
+27.2%
78,904
+8.7%
0.00%
+100.0%
Q2 2022$2,100,000
-9.3%
72,620
+1.4%
0.00%0.0%
Q1 2022$2,316,000
+16.3%
71,644
+4.9%
0.00%0.0%
Q4 2021$1,992,000
+36.2%
68,329
+24.5%
0.00%0.0%
Q3 2021$1,463,000
-2.6%
54,873
+12.5%
0.00%0.0%
Q2 2021$1,502,000
+47.1%
48,774
+25.1%
0.00%0.0%
Q1 2021$1,021,000
+192.6%
38,996
+181.5%
0.00%
Q4 2020$349,000
+71.1%
13,853
+41.6%
0.00%
Q3 2020$204,000
-18.4%
9,782
-7.0%
0.00%
Q2 2020$250,000
+25.0%
10,523
-5.2%
0.00%
Q1 2020$200,000
-48.3%
11,096
-32.0%
0.00%
Q4 2019$387,000
-48.3%
16,326
-40.1%
0.00%
-100.0%
Q3 2019$748,000
-40.7%
27,234
-28.5%
0.00%
-50.0%
Q2 2019$1,261,000
-6.9%
38,102
-1.4%
0.00%0.0%
Q1 2019$1,354,000
+8.1%
38,644
+2.4%
0.00%0.0%
Q4 2018$1,253,000
+35.9%
37,724
+144.9%
0.00%0.0%
Q2 2018$922,000
+24.1%
15,406
-5.0%
0.00%0.0%
Q1 2018$743,000
-72.8%
16,212
-76.4%
0.00%
-66.7%
Q4 2017$2,734,000
+2.6%
68,599
+2.9%
0.01%0.0%
Q3 2017$2,666,000
-12.3%
66,635
-5.6%
0.01%
-25.0%
Q2 2017$3,040,000
+273.9%
70,577
+171.3%
0.01%
+166.7%
Q1 2017$813,000
+19.9%
26,011
-3.2%
0.00%
+50.0%
Q4 2016$678,000
-6.2%
26,876
-8.0%
0.00%
-33.3%
Q3 2016$723,000
-5.9%
29,227
-22.4%
0.00%0.0%
Q2 2016$768,000
+27.8%
37,681
-4.4%
0.00%0.0%
Q1 2016$601,000
+111.6%
39,418
+86.8%
0.00%
+200.0%
Q4 2015$284,000
+6.4%
21,098
+11.0%
0.00%0.0%
Q3 2015$267,000
+32.8%
19,014
+60.4%
0.00%0.0%
Q2 2015$201,00011,8560.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders